Drug intelligence / Profile preview

Fertimacy

Development stage
Unknown
Lead developer
Delfran Pharmaceuticals
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical
01

Overview

Fertimacy is a topical vaginal gel developed by Delfran Pharmaceuticals, a South African company specializing in infertility and female healthcare. Although marketed within a fertility-focused product line, the gel is primarily indicated for the relief of feminine discomfort, itching, and odor. Its formulation is designed to maintain the natural physiological conditions of the vagina and preserve the balance of the vaginal ecosystem. The primary active ingredient is Polyhexamethylene biguanide hydrochloride (PHMB) at a 0.2% concentration, which serves as a broad-spectrum antimicrobial agent. The product is specifically formulated to be lactobacilli-sparing and matches the natural pH of the vagina. It is typically supplied in single-dose, pre-filled 3ml applicators for topical vaginal administration.

Brand names
Fertimacy

Beyond the preview

Go deeper on Fertimacy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fertimacy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call